 |
Pharmaceutical cGMPs for the 21st Century - A Risk-Based Approach
September 30, 2004
"In August 2002, the Food and Drug Administration (FDA or the Agency) announced a significant new initiative, Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st Century, to enhance and modernize the regulation of pharmaceutical manufacturing and product quality — to bring a 21st century focus to this critical FDA responsibility."
Final Report
|
|
|
|
